Autres langues BrainsWay Ltd.

Actions

BWAY

IL0011007189

Marché Fermé - TEL AVIV STOCK EXCHANGE Autres places de cotation 16:24:19 16/07/2024			Varia. 5j.	Varia. 1 janv.
1 227 ^ILa	+1,49 %		+6,23 %	+6,79 %

17/06	BrainsWay Ltd. élargit sa présence mondiale en signant un accord de distribution exclusif pluriannuel au Canada	CI
10/06	BrainsWay Ltd. lance un essai clinique prospectif, randomisé, contrôlé et multicentrique évaluant un protocole accéléré de traitement de la dépression par SMT profond pour le mois de juin 2024	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

BrainsWay : Q1 2024	16/07
BrainsWay : Immediate Report	17/06
BrainsWay : Results of Annual Shareholder Meeting Form 6 K	17/06
BrainsWay Expands Global Imprint with Exclusive Multi-Year Distribution Agreement in Canada	17/06
BrainsWay Ltd. Expands Global Imprint with Exclusive Multi-Year Distribution Agreement in Canada	17/06
BrainsWay Ltd. Launches Prospective, Randomized, Controlled, Multicenter Trial Evaluating Accelerated Deep TMS for Depression for the Month of June 2024	10/06
BrainsWay Launches Prospective, Randomized, Controlled, Multicenter Trial Evaluating Accelerated Deep TMS™ for Depression	10/06
Brainsway's Deep Transcranial Magnetic Stimulation Gets Expanded FDA Labeling; Shares Rise	03/06
BrainsWay : Deep TMS™ Becomes the First and Only TMS Device Indicated for Depression Treatment in Patients Between the Ages of 68 and 86 - Form 6-K	03/06
BrainsWay Receives Expanded FDA Labeling to Treat Late Life Depression	03/06
BrainsWay Ltd. Receives Expanded FDA Labeling to Treat Late Life Depression	03/06
BrainsWay : Corporate Presentation May 2024	20/05
BrainsWay : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS - Form 6-K	09/05
BrainsWay : Immediate Report of Meeting	09/05
BrainsWay Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05
BrainsWay Reports First Quarter 2024 Financial Results and Operational Highlights	08/05
BrainsWay Ltd. Reiterates Revenue Guidance for the Year 2024	08/05
BrainsWay to Report First Quarter 2024 Financial Results on May 8, 2024	24/04
BrainsWay Expands Deep TMS™ Access in Israel Following Significant Increase in Reimbursement Rates	17/04
Brainsway Expands Deep Tms Access in Israel Following Significant Increase in Reimbursement Rates	17/04

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues BrainsWay Ltd.

Actions

BWAY

IL0011007189

Autres langues

Filtres